Standout Papers

Mutant MHC class II epitopes drive therapeutic immune responses to cancer 2015 2026 2018 2022 892
  1. Mutant MHC class II epitopes drive therapeutic immune responses to cancer (2015)
    Sebastian Kreiter, Mathias Vormehr et al. Nature
  2. Identification of neoantigens for individualized therapeutic cancer vaccines (2022)
    Franziska Lang, Barbara Schrörs et al. Nature Reviews Drug Discovery

Immediate Impact

17 by Nobel laureates 24 from Science/Nature 66 standout
Sub-graph 1 of 18

Citing Papers

Probiotic neoantigen delivery vectors for precision cancer immunotherapy
2024 StandoutNature
Personalized neoantigen vaccine and pembrolizumab in advanced hepatocellular carcinoma: a phase 1/2 trial
2024 Standout

Works of Barbara Schrörs being referenced

A liposomal RNA vaccine inducing neoantigen-specific CD4 + T cells augments the antitumor activity of local radiotherapy in mice
2020
Mutant MHC class II epitopes drive therapeutic immune responses to cancer
2015 StandoutNature

Author Peers

Author Last Decade Papers Cites
Barbara Schrörs 1188 975 748 21 1.7k
Mathias Vormehr 1212 965 814 23 1.7k
Nienke van Rooij 1279 1140 598 22 1.9k
Jan Diekmann 1373 1090 694 12 1.7k
Saghar Kaabinejadian 1226 887 812 19 1.7k
Iñaki Etxeberría 1118 1016 604 25 1.8k
Zhichen Sun 785 612 436 31 1.4k
Saray Garasa 1346 1085 469 36 2.0k
Sander Kelderman 1175 1397 515 12 2.0k
Marit M. van Buuren 1633 1699 667 17 2.2k
Alfonso R. Sánchez-Paulete 1452 1279 392 28 2.0k

All Works

Loading papers...

Rankless by CCL
2026